22nd Annual International Congress on Hematologic Malignancies Abstract Submission
22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and Myeloma22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and Myeloma -- Call for Poster Abstracts!
The 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and Myeloma
(HEM) Program Chairs invite you to submit your abstracts for this year's International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and Myeloma
to be held March 1 through March 4, 2018, at THE DIPLOMAT in Hollywood, FL.
Deadline for submission has passed.
All poster abstract submissions must be made electronically through the Congress' online abstract submission system.
Your abstract should be a short description of your work and contain all the elements necessary to define your goals and results to the reader. Authors will be required to disclose all financial relationships through the online system, helping to ensure quality and unbiased presentations. The formal poster session is not designated for credit.
Share your research or best practices with your peers. Categories of submission include:
Acute lymphoblastic leukemia
Acute myeloid leukemia
Chronic lymphocytic leukemia
Chronic myeloid leukemia
Other blood cell disorders, including ITP
Other, including preclinical studies
The Program Chairs will evaluate the scientific quality of the submitted abstracts on the basis of the following criteria: novelty of the research, significance of the findings, and clarity. Incomplete abstracts will not be reviewed. Please note that we will consider case series, but are not accepting single-patient case reports.
Notification of acceptance or regret will be delivered via e-mail to the presenter(s) of each poster abstract by mid February. Please note that an author is required to be present during the poster session.
If accepted for presentation, abstracts and posters will be available for viewing online on the 2018 Congress website during and after the conference. The posters will be displayed for the length of the conference. The presentation at the 22nd Annual International Congress on Hematologic Malignancies®
should reflect the submitted abstract-abstract title, authorship, and content of the presentation at the 22nd Annual International Congress on Hematologic Malignancies®
must match the submitted abstract.
All presenters must register to attend the 22nd Annual International Congress on Hematologic Malignancies®
: Focus on Leukemias, Lymphomas and Myeloma
. Please click here
Components of the Abstract Body-Limit: 2500 Characters (1 table allowed)
Complete the abstract template provided on the 2018 Congress website.
Limit is 2500 characters (abstract body, including spaces and table).
Upload full abstract or poster where prompted.
Please submit any questions pertaining to abstract submissions to email@example.com using the subject line "HEM Abstract QUESTION."
Background/Significance -What was the problem and why was it important? What knowledge are you building on? What was the intent or goal of the study? What did you want to learn?
Materials and Methods -What was the trial design? What was the sample? What instruments were used? How were data collected and analyzed?
Results -What were the findings?
Conclusions -What do the findings mean?
Author Consent and Waiver of Claims
Each Abstract Author agrees and certifies that he or she:
Waives any and all claims against Physicians' Education Resource®, LLC, sponsor of the 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and Myeloma, and any review arising out of or relating to the abstract submission and review process, including but not limited to peer review and the grading of abstracts.
Note: The hotel is expected to sell out, and it is likely to do so before the discounted cutoff date of 2/7/2018
. Reservations may be made online here.